SILO PHARMA, INC. Prepaid Expense and Other Assets
SILO PHARMA, INC. (SILO) had Prepaid Expense and Other Assets of $121.33 thousand as of 2023-06-30, per its 10-Q filed 2023-08-11.
Discontinued › Balance Sheet › Assets › Prepaid Expense and Other Assets
us-gaap:PrepaidExpenseAndOtherAssets · last filed 2023-08-11
- 2023-06-30: Prepaid Expense and Other Assets $121.33K.
- 2023-03-31: Prepaid Expense and Other Assets $204.35K.
- 2022-12-31: Prepaid Expense and Other Assets $135.89K.
- 2022-09-30: Prepaid Expense and Other Assets $581.37K.
| Period end | Prepaid Expense and Other Assets |
|---|---|
| 2023-06-30 | $121.33K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $204.35K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $135.89K 10-Q · filed 2023-08-11 |
| 2022-09-30 | $581.37K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $99.94K 10-Q · filed 2022-08-01 |
| 2022-03-31 | $206.45K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $145.32K 10-K · filed 2023-03-24 |
| 2021-09-30 | $220.59K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $167.59K 10-Q · filed 2021-08-13 |
| 2021-03-31 | $230.41K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $241.09K 10-K · filed 2022-03-28 |
| 2020-09-30 | $310.98K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $525.34K 10-Q · filed 2020-08-14 |
| 2019-12-31 | $16.33K 10-K/A · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |